deoxyepinephrine has been researched along with Arrhythmia in 10 studies
Deoxyepinephrine: Sympathomimetic, vasoconstrictor agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibopamine is a dopaminergic and adrenergic receptor agonist, which is active in the treatment of congestive heart failure." | 9.06 | Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. ( , 1989) |
| "The substitution of digoxin with ibopamine, a new inotropic and vasodilating agent, was evaluated in a multicenter study in 58 patients with mild-to-moderate congestive heart failure, stabilized on diuretics, and digoxin therapy." | 9.06 | Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group. ( Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M, 1989) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 7.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 6.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| "Ibopamine is a dopaminergic and adrenergic receptor agonist, which is active in the treatment of congestive heart failure." | 5.06 | Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study. ( , 1989) |
| "The substitution of digoxin with ibopamine, a new inotropic and vasodilating agent, was evaluated in a multicenter study in 58 patients with mild-to-moderate congestive heart failure, stabilized on diuretics, and digoxin therapy." | 5.06 | Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group. ( Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M, 1989) |
| "This study compares the effects of digoxin, placebo and ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyl-dopamine, on exercise tolerance and cardiac rhythm of 14 patients whose left ventricular heart failure (end-diastolic pressure, 26." | 5.06 | Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure. ( Brusoni, B; Cadel, A; Carati, L; Fanciulli, R; Osculati, G; Pirelli, P; Rovati, A; Valagussa, F, 1986) |
| "Seven male patients suffering from angina pectoris with spontaneous premature ventricular beats were given oral ibopamine 50 mg t." | 3.66 | Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. ( Maggi, GC; Montani, E; Triulzi, MO, 1982) |
| " The results rather suggest that long-term treatment with ibopamine affords an increase in survival and a delay in the progression of the disease, without adverse effects on cardiac rhythm and myocardial oxygen balance, and with a general improvement in the patients' quality of life." | 2.67 | Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results. ( Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F, 1991) |
| "Ibopamine was not found to facilitate the occurrence of atrial and/or ventricular arrhythmias." | 1.27 | The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies. ( Breccia Fratadocchi, G; Capestro, F; Ciampani, N; Massacci, C; Mocchegiani, R; Purcaro, A; Ruga, O, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (80.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montani, E | 1 |
| Triulzi, MO | 1 |
| Maggi, GC | 1 |
| Sher, D | 2 |
| Licciardello, L | 3 |
| Ferrari, V | 2 |
| Sirtori, F | 1 |
| Cesana, B | 1 |
| Caponnetto, S | 2 |
| Terrachini, V | 2 |
| Canale, C | 2 |
| Bruzzone, F | 2 |
| Masperone, MA | 1 |
| Pastorino, L | 1 |
| Marchetti, GV | 2 |
| Cavalli, A | 1 |
| Riva, E | 1 |
| Schleman, M | 1 |
| Abbondati, G | 1 |
| Fuccella, LM | 1 |
| Goldberg, LI | 1 |
| Rajfer, SI | 1 |
| Ciampani, N | 1 |
| Massacci, C | 1 |
| Capestro, F | 1 |
| Breccia Fratadocchi, G | 1 |
| Mocchegiani, R | 1 |
| Ruga, O | 1 |
| Purcaro, A | 1 |
| Cadel, A | 1 |
| Brusoni, B | 1 |
| Pirelli, P | 1 |
| Osculati, G | 1 |
| Rovati, A | 1 |
| Fanciulli, R | 1 |
| Carati, L | 1 |
| Valagussa, F | 1 |
6 trials available for deoxyepinephrine and Arrhythmia
| Article | Year |
|---|---|
Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; C | 1991 |
Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiotonic Agen | 1989 |
Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine | 1989 |
Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.
Topics: Adult; Aged; Arrhythmias, Cardiac; Deoxyepinephrine; Digoxin; Dopamine; Echocardiography; Exercise T | 1989 |
Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Diseases; Deoxyepine | 1987 |
Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine; Female; Heart F | 1986 |
4 other studies available for deoxyepinephrine and Arrhythmia
| Article | Year |
|---|---|
Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Deoxyepinephrine; Dopamine; Electrocardiography; Heart | 1982 |
Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Cardiotonic Agents; D | 1990 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopa | 1985 |
The diisobutyryl ester of N-methyldopamine, ibopamine: evaluation of electrophysiological properties and arrhythmogenicity studies.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Electrocardiograp | 1986 |